Barrington Keith J, Fortin-Pellerin Etienne, Pennaforte Thomas
Department of Pediatrics, CHU Ste-Justine, 3175 Cote Ste Catherine, Montreal, QC, Canada, H3T 1C5.
Department of Neonatology, Sainte Justine University Health Center, 3175 Cote Sainte Catherine, Montreal, QC, Canada, H3T 1C5.
Cochrane Database Syst Rev. 2017 Feb 8;2(2):CD005389. doi: 10.1002/14651858.CD005389.pub2.
Fluid restriction is often recommended as part of the management of infants with early or established bronchopulmonary dysplasia (BPD).
To determine whether fluid restriction as part of the therapeutic intervention for early or established BPD improves clinical outcomes.
We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 1) in the Cochrane Library (searched 16 February 2016), MEDLINE via PubMed (1966 to 16 February 2016), Embase (1980 to 16 February 2016), and CINAHL (1982 to 16 February 2016). We also searched clinical trials' databases, conference proceedings, and the reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials.
Prospective randomised clinical trials comparing two distinct fluid administration volumes in preterm infants with early or established BPD.
We used the standard methods of Cochrane Neonatal. For the included trial, we extracted data and assessed the risk of bias, and used GRADE methods to assess the quality of the evidence. The outcomes considered in this review are effects on mortality or requirement for oxygen at 36 weeks' postmenstrual age (primary outcome measure), the duration of supplemental oxygen therapy, proportion of infants discharged from hospital on oxygen, duration of assisted ventilation, duration of hospitalisation, weight gain, feeding tolerance, apnoea, necrotizing enterocolitis, renal dysfunction or nephrocalcinosis, lung mechanics, and use of diuretic therapy (secondary outcome measures).
One trial was found, including 60 preterm infants at 28 days of age with persistent oxygen requirements. Infants were randomised to either 180 mL/kg/day of standard formula or 145 mL/kg/day of concentrated formula. This single study did not provide data regarding our primary outcome. No effects of the intervention were found on any of our secondary outcomes. The quality of the evidence from this study was graded low.
AUTHORS' CONCLUSIONS: There is no evidence to support the practice of fluid restriction in infants with early or established BPD.
液体限制常被推荐作为早期或已确诊支气管肺发育不良(BPD)婴儿管理的一部分。
确定液体限制作为早期或已确诊BPD治疗干预的一部分是否能改善临床结局。
我们采用Cochrane新生儿组的标准检索策略,检索Cochrane图书馆中的Cochrane对照试验中心注册库(CENTRAL;2016年第1期)(检索日期为2016年2月16日)、通过PubMed检索MEDLINE(1966年至2016年2月16日)、Embase(1980年至2016年2月16日)和CINAHL(1982年至2016年2月16日)。我们还检索了临床试验数据库、会议论文集以及检索到的随机对照试验和半随机试验文章的参考文献列表。
比较早期或已确诊BPD早产儿两种不同液体摄入量的前瞻性随机临床试验。
我们采用Cochrane新生儿组的标准方法。对于纳入的试验,我们提取数据并评估偏倚风险,采用GRADE方法评估证据质量。本综述考虑的结局包括对36周龄时死亡率或吸氧需求的影响(主要结局指标)、补充氧气治疗的持续时间、出院时仍需吸氧的婴儿比例、辅助通气的持续时间、住院时间、体重增加、喂养耐受性、呼吸暂停、坏死性小肠结肠炎、肾功能障碍或肾钙质沉着、肺力学以及利尿剂治疗的使用情况(次要结局指标)。
找到一项试验,纳入60名28日龄仍持续需要吸氧的早产儿。婴儿被随机分为接受180 mL/kg/天的标准配方奶或145 mL/kg/天的浓缩配方奶。这项单一研究未提供关于我们主要结局的数据。在我们的任何次要结局上均未发现干预的效果。该研究证据质量等级为低。
没有证据支持对早期或已确诊BPD婴儿进行液体限制的做法。